Investor Alert

press release

Jan. 5, 2022, 4:05 p.m. EST

Dynavax to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference

EMERYVILLE, Calif., Jan. 5, 2022 /PRNewswire/ --  Dynavax Technologies Corporation /zigman2/quotes/203017054/composite DVAX -1.14% , a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ryan Spencer , Chief Executive Officer, will present at the H.C. Wainwright Virtual BioConnect 2022 Conference being held January 10-13, 2022.

The on demand presentation will be available, beginning Monday, January 10, 2022 at 7:00 a.m. E.T. and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at http://investors.dynavax.com/events-presentations .

About Dynavax Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. The Company's first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. and the European Union for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018 adjuvant as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, plague, Tdap, seasonal influenza and universal influenza. For more information, visit www.dynavax.com and follow the company on LinkedIn .

Contacts: Nicole Arndt

Derek Cole, President
Investor Relations Advisory Solutions

View original content to download multimedia: https://www.prnewswire.com/news-releases/dynavax-to-present-at-the-hc-wainwright-virtual-bioconnect-2022-conference-301454785.html

SOURCE Dynavax Technologies


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2022 PR Newswire. All rights reserved

US : U.S.: Nasdaq
$ 11.28
-0.13 -1.14%
Volume: 4.46M
May 24, 2022 4:00p
P/E Ratio
Dividend Yield
Market Cap
$1.44 billion
Rev. per Employee


Partner Center

Link to MarketWatch's Slice.